Comments

Adverum Biotechnologies Stock Price, Quotes and Forecasts

Q: What sector and industry does Adverum Biotechnologies (ADVM) operate in?

Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

ADVMNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Adverum Biotechnologies (ADVM) Forecast

News Earnings Adverum Biotechnologies (ADVM) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Adverum Biotechnologies Stock Price, Quotes and Forecasts | NASDAQ:ADVM | Benzinga

Explore Adverum Biotechnologies stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ADVM.

Open	$4.45
Close	-
Volume / Avg.	102.67K / 175.51K
Day Range	$4.14 - $4.76
52 Wk Range	3.52 - 14.82
Market Cap	$92.99M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	7.18%
Days to Cover	11

Recent News

Around $88M Bet On NextDecade? Check Out These 3 Stocks Insiders Are Buying

Avi Kapoor

More Than $10M Bet On Appian? Check Out These 3 Stocks Insiders Are Buying

Avi Kapoor

Is Adverum Biotechnologies Stock Outpacing Its Medical Peers This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has Adverum Biotechnologies (NASDAQ: ADVM) been one of those stocks this year?

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$4.45
Close	-
Volume / Avg.	102.67K / 175.51K
Day Range	$4.14 - $4.76
52 Wk Range	3.52 - 14.82
Market Cap	$92.99M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	44
Short Interest	7.18%
Days to Cover	11

About Adverum Biotechnologies Inc

Sector

Health Care

Industry

Biotechnology

Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene th...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Adverum Biotechnologies (ADVM) stock?

You can purchase shares of Adverum Biotechnologies (NASDAQ:ADVM) through any online brokerage.

View our list of the best stock brokerages

Who are Adverum Biotechnologies (ADVM) competitors?

Other companies in Adverum Biotechnologies’s space includes: Renovaro (NASDAQ:RENB), Anixa Biosciences (NASDAQ:ANIX), Galectin Therapeutics (NASDAQ:GALT), OncoCyte (NASDAQ:OCX) and Atossa Therapeutics (NASDAQ:ATOS).

What is the forecast, or price target, for Adverum Biotechnologies (ADVM) stock?

Adverum Biotechnologies has a consensus price target of $24.14.

What is the current price for Adverum Biotechnologies (ADVM)?

The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $4.35 last updated March 31, 2025 at 1:10 PM EDT.

Does Adverum Biotechnologies (ADVM) pay a dividend?

There are no upcoming dividends for Adverum Biotechnologies.

When is Adverum Biotechnologies (NASDAQ:ADVM) reporting earnings?

Adverum Biotechnologies’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Adverum Biotechnologies (ADVM) going to split?

There is no upcoming split for Adverum Biotechnologies.

What sector and industry does Adverum Biotechnologies (ADVM) operate in?

Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.